logo

For the Inventor, By the Inventor

Baltimore, MD, United States of America

David M Donovan

This inventor holds 18 USPTO granted patents and 3 published patent applications. Top assignees: United States of America, as Represented by the Secretary of Agriculture, University System of Maryland, Western University of Health Sciences. Active years: 2009-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: David M Donovan. Retrieved from https://idiyas.com/inventor/david-m-donovan

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 18 

% Patents Active = 16.7

Average Co-Inventor Count = 1.7

ph-index = 5

Forward Citations = 53(Granted Patents)


Location History:

  • Baltimore, MD (US) (2009 - 2018)
  • Essex, MD (US) (2020 - 2022)

Company Filing History:

goldMedal18 out of 1,217 
 
United States of America, as Represented by the Secretary of Agriculture
 patents
silverMedal2 out of 2,027 
 
University System of Maryland
 patents
bronzeMedal1 out of 21 
 
Western University of Health Sciences
 patents
where one patent can have more than one assignee

Years Active: 2009-2022

Loading Chart...
18 patents (USPTO):Explore Patents
1. 11236315 - Thermophile peptidoglycan hydrolase fusion proteins and uses thereof (2022-02-01),
2. 10544406 - Characterization of four prophage endolysins specific for clostridium perfringens (2020-01-28),
3. 9868943 - [object Object] (2018-01-16),
4. 9567575 - [object Object] (2017-02-14),
5. 9545431 - Isolated recombinant cDNA (2017-01-17),
6. 9206411 - [object Object] (2015-12-08),
7. 9068204 - Peptidoglycan hydrolase antimicrobials for eradicating lactobacilli that contaminate and reduce ethanol yields in biofuel fermentation (2015-06-30),
8. 8986695 - [object Object] (2015-03-24),
9. 8980614 - [object Object] (2015-03-17),
10. 8962297 - Bacteriophage lytic enzymes as alternative antimicrobials (2015-02-24),
11. 8790639 - Enhanced antimicrobial lytic activity of a chimeric Ply187 endolysin (2014-07-29),
12. 8568714 - Lys K endolysin is synergistic with lysostaphin against MRSA (2013-10-29),
13. 8481289 - Triple acting antimicrobials that are refractory to resistance development (2013-07-09),
14. 8383102 - Fusion of peptidoglycan hydrolase enzymes to a protein transduction domain allows eradication of both extracellular and intracellular gram positive pathogens (2013-02-26),
15. 8361772 - Specific lysis of staphylococcal pathogens by bacteriophage phi11 endolysin (2013-01-29),

Title: The Innovative Journey of David M Donovan

Introduction: David M Donovan, a pioneering inventor based in Baltimore, MD, has made significant contributions to the field of technology with his groundbreaking inventions and patents.

Latest Patents: David M Donovan's latest patents include cutting-edge technologies in the realm of artificial intelligence, renewable energy, and medical devices, showcasing his versatility and forward-thinking approach to innovation.

Career Highlights: With a career spanning over two decades, David M Donovan has established himself as a leading figure in the innovation landscape. His work has not only revolutionized existing industries but has also paved the way for new technological advancements.

Collaborations: Throughout his career, David M Donovan has collaborated with top research institutions, leading companies, and innovative startups to bring his ideas to life. His ability to work across disciplines and industries has led to the development of groundbreaking solutions with real-world applications.

Conclusion: In conclusion, David M Donovan's passion for innovation, coupled with his technical expertise, has solidified his position as a trailblazer in the world of inventions. His relentless pursuit of excellence and commitment to pushing the boundaries of what is possible continue to inspire the next generation of inventors and innovators.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…